1620-1621 / 2351
DAHANCA 18: morbidity
100
(%)
80
feeding
64%
60
of tube
36%
40
pendent
12%
4%
20
ents de
0
During C‐RT 2 mo
5‐8 mo
12 mo
Pati
Benzten et al Acta Oncol 2015
|
|
1620-1621 / 2351
DAHANCA 18: morbidity
100
(%)
80
feeding
64%
60
of tube
36%
40
pendent
12%
4%
20
ents de
0
During C‐RT 2 mo
5‐8 mo
12 mo
Pati
Benzten et al Acta Oncol 2015